Carmat SA
PAR:ALCAR

Watchlist Manager
Carmat SA Logo
Carmat SA
PAR:ALCAR
Watchlist
Price: 1.408 EUR -3.56%
Market Cap: 50.5m EUR
Have any thoughts about
Carmat SA?
Write Note

Intrinsic Value

ALCAR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ALCAR stock under the Base Case scenario is 4.534 EUR. Compared to the current market price of 1.408 EUR, Carmat SA is Undervalued by 69%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALCAR Intrinsic Value
4.534 EUR
Undervaluation 69%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Carmat SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALCAR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALCAR?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Carmat SA

Provide an overview of the primary business activities
of Carmat SA.

What unique competitive advantages
does Carmat SA hold over its rivals?

What risks and challenges
does Carmat SA face in the near future?

Has there been any significant insider trading activity
in Carmat SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Carmat SA.

Provide P/S
for Carmat SA.

Provide P/E
for Carmat SA.

Provide P/OCF
for Carmat SA.

Provide P/FCFE
for Carmat SA.

Provide P/B
for Carmat SA.

Provide EV/S
for Carmat SA.

Provide EV/GP
for Carmat SA.

Provide EV/EBITDA
for Carmat SA.

Provide EV/EBIT
for Carmat SA.

Provide EV/OCF
for Carmat SA.

Provide EV/FCFF
for Carmat SA.

Provide EV/IC
for Carmat SA.

Show me price targets
for Carmat SA made by professional analysts.

What are the Revenue projections
for Carmat SA?

How accurate were the past Revenue estimates
for Carmat SA?

What are the Net Income projections
for Carmat SA?

How accurate were the past Net Income estimates
for Carmat SA?

What are the EPS projections
for Carmat SA?

How accurate were the past EPS estimates
for Carmat SA?

What are the EBIT projections
for Carmat SA?

How accurate were the past EBIT estimates
for Carmat SA?

Compare the revenue forecasts
for Carmat SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Carmat SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Carmat SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Carmat SA compared to its peers.

Compare the P/E ratios
of Carmat SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Carmat SA with its peers.

Analyze the financial leverage
of Carmat SA compared to its main competitors.

Show all profitability ratios
for Carmat SA.

Provide ROE
for Carmat SA.

Provide ROA
for Carmat SA.

Provide ROIC
for Carmat SA.

Provide ROCE
for Carmat SA.

Provide Gross Margin
for Carmat SA.

Provide Operating Margin
for Carmat SA.

Provide Net Margin
for Carmat SA.

Provide FCF Margin
for Carmat SA.

Show all solvency ratios
for Carmat SA.

Provide D/E Ratio
for Carmat SA.

Provide D/A Ratio
for Carmat SA.

Provide Interest Coverage Ratio
for Carmat SA.

Provide Altman Z-Score Ratio
for Carmat SA.

Provide Quick Ratio
for Carmat SA.

Provide Current Ratio
for Carmat SA.

Provide Cash Ratio
for Carmat SA.

What is the historical Revenue growth
over the last 5 years for Carmat SA?

What is the historical Net Income growth
over the last 5 years for Carmat SA?

What is the current Free Cash Flow
of Carmat SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Carmat SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Carmat SA

Current Assets 43.4m
Cash & Short-Term Investments 11.4m
Receivables 4.5m
Other Current Assets 27.5m
Non-Current Assets 10.7m
Long-Term Investments 540k
PP&E 10.1m
Intangibles 85k
Other Non-Current Assets 1k
Current Liabilities 12.5m
Accounts Payable 5.4m
Accrued Liabilities 7.1m
Other Current Liabilities 11k
Non-Current Liabilities 64.2m
Long-Term Debt 58.5m
Other Non-Current Liabilities 5.7m
Efficiency

Earnings Waterfall
Carmat SA

Revenue
5.5m EUR
Cost of Revenue
-35.1m EUR
Gross Profit
-29.6m EUR
Operating Expenses
-22.4m EUR
Operating Income
-52m EUR
Other Expenses
-1.3m EUR
Net Income
-53.4m EUR

Free Cash Flow Analysis
Carmat SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALCAR Profitability Score
Profitability Due Diligence

Carmat SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional ROE
Exceptional 1-Year Revenue Growth
ROE is Increasing
31/100
Profitability
Score

Carmat SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

ALCAR Solvency Score
Solvency Due Diligence

Carmat SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
47/100
Solvency
Score

Carmat SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALCAR Price Targets Summary
Carmat SA

Wall Street analysts forecast ALCAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALCAR is 7.723 EUR with a low forecast of 4.04 EUR and a high forecast of 18.9 EUR.

Lowest
Price Target
4.04 EUR
187% Upside
Average
Price Target
7.723 EUR
448% Upside
Highest
Price Target
18.9 EUR
1 242% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALCAR?

Click here to dive deeper.

Dividends

Carmat SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ALCAR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALCAR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Carmat SA Logo
Carmat SA

Country

France

Industry

Health Care

Market Cap

49.5m EUR

Dividend Yield

0%

Description

Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 160 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.

Contact

ILE-DE-FRANCE
Velizy-Villacoublay
36, avenue de l'Europe, Immeuble l'Etendard
+33139456450.0
www.carmatsa.com

IPO

2010-07-07

Employees

160

Officers

CEO & Director
Mr. Stephane Piat
CFO & Head of investor relations
Ms. Pascale d'Arbonneau
Human Resources Director
Ms. Raouia Bouyanzer
Chief Medical Officer
Dr. Petrus Jansen

See Also

Discover More
What is the Intrinsic Value of one ALCAR stock?

The intrinsic value of one ALCAR stock under the Base Case scenario is 4.534 EUR.

Is ALCAR stock undervalued or overvalued?

Compared to the current market price of 1.408 EUR, Carmat SA is Undervalued by 69%.

Back to Top